Literature DB >> 10037223

New monoclonal antibodies against a recombinant second envelope protein of Hepatitis C virus.

M Inudoh1, N Kato, Y Tanaka.   

Abstract

To study the immunological features of the hepatitis C virus (HCV) envelope protein (E2 protein), new specific monoclonal antibodies (mAbs) were generated. WKA/H rats were immunized with syngeneic cells infected with a vaccinia virus expressing the E2 protein and with soluble E2 protein obtained from Chinese hamster ovary cells with a plasmid-based expression system. By screening hybridoma cells obtained from spleen cells of the immunized rats, three specific mAbs were obtained. One mAb was reactive to a peptide corresponding to the hypervariable region 1 (HVR1) in E2 protein, while the others reacted to regions outside HVR1. The significance of these antibodies for the diagnosis of HCV infection as well as for analysis of the structure of the HCV E2 protein will be discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10037223     DOI: 10.1111/j.1348-0421.1998.tb02364.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  5 in total

1.  A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity.

Authors:  Kozi Ichiyama; Sei Yokoyama-Kumakura; Yuetsu Tanaka; Reiko Tanaka; Kunitaka Hirose; Kenji Bannai; Takeo Edamatsu; Mikiro Yanaka; Yoshiaki Niitani; Naoko Miyano-Kurosaki; Hiroshi Takaku; Yoshio Koyanagi; Naoki Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

2.  Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection.

Authors:  R Tanaka; A Yoshida; T Murakami; E Baba; J Lichtenfeld; T Omori; T Kimura; N Tsurutani; N Fujii; Z X Wang; S C Peiper; N Yamamoto; Y Tanaka
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.

Authors:  Tetsuya Adachi; Reiko Tanaka; Akira Kodama; Mineki Saito; Yoshiaki Takahashi; Aftab A Ansari; Yuetsu Tanaka
Journal:  Retrovirology       Date:  2011-10-22       Impact factor: 4.602

4.  Activation of the interferon-inducible 2'-5'-oligoadenylate synthetase gene by hepatitis C virus core protein.

Authors:  A Naganuma; A Nozaki; T Tanaka; K Sugiyama; H Takagi; M Mori; K Shimotohno; N Kato
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Natural OX40L expressed on human T cell leukemia virus type-I-immortalized T cell lines interferes with infection of activated peripheral blood mononuclear cells by CCR5-utilizing human immunodeficiency virus.

Authors:  Daigo Kasahara; Azusa Takara; Yoshiaki Takahashi; Akira Kodama; Reiko Tanaka; Aftab A Ansari; Yuetsu Tanaka
Journal:  Virol J       Date:  2013-11-18       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.